Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of contraceptive DNA vaccine and preparation method thereof

A technology of DNA vaccines and nucleotide sequences, which can be used in pharmaceutical formulations, medical preparations containing active ingredients, antibody medical ingredients, etc., and can solve problems such as failure, irreversibility, and harmfulness to the body

Inactive Publication Date: 2020-08-18
PEKING UNIV SHENZHEN HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are few contraceptive measures available to men, and these measures have serious disadvantages such as harmful to the body, possible failure and irreversibility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of contraceptive DNA vaccine and preparation method thereof
  • A kind of contraceptive DNA vaccine and preparation method thereof
  • A kind of contraceptive DNA vaccine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1: Preparation of the DNA vaccine of the present invention

[0051] PCR amplification was performed with pYA3149-Bin1b as the template to obtain the target fragment with a size of 337bp, and the agarose gel electrophoresis detection was consistent with the expected size ( Image 6 ). Among them, the PCR amplification procedure is:

[0052] Pre-denaturation at 94°C for 5min;

[0053] Denaturation at 94°C for 30s, renaturation at 55°C for 30s, extension at 72°C for 60s, cycle 30 times;

[0054] Extend at 72°C for 10 min and store at 4°C.

[0055] The PCR amplification system is:

[0056]

[0057] add ddH 2 O to 50ul, mix well.

[0058] The PCR products and pSG.SS.C3d3.YL and pSG.SS.YL were digested with BglII, respectively, and were recovered with a PCR product purification kit. The recovered products were digested with BamHI, and digested with 0.8% agarose gel electrophoresis. After the product is obtained, the gel containing the target fragment and the...

Embodiment 2

[0060] Example 2: Validation of recombinant plasmids

[0061] The extracted plasmids pSG.SS.C3d3.Bin1b and pSG.SS.YL.Bin1b were identified by double digestion with BglII and BamHI, and the PCR results were used as control. 0.8% agarose gel electrophoresis digestion results showed that the band near 337bp was the target fragment after digestion, and the sequencing results also showed that this fragment was the target gene, indicating that pSG.SS.C3d3.YL.Bin1b and pSG. SS.YL.Bin1b was built successfully.

Embodiment 3

[0062] Example 3: Indirect immunofluorescence detection of recombinant plasmid Bin1b expression

[0063] Human embryonic kidney HEK293 cells were transfected with pSG.SS.C3d3.YL.Bin1b and pSG.SS.YL.Bin1b, and transfected using Lipofectamine transfection kit.

[0064] After 48 hours of transfection, the coverslips were taken out and fixed in ice acetone for 5 minutes. Enzyme repair and antigen blocking were performed according to the SP9000 kit. Bin1b antibody (1:400) was added and incubated for 40 minutes. Goat IgG (1:500 dilution) was incubated at room temperature for 30 minutes, and the results were observed by fluorescence microscope.

[0065] Compared with the negative immunofluorescence results of pSG.SS.C3d3.YL empty vector, the expression results of pSG.SS.YL.Bin1b and pSG.SS.C3d3.YL.Bin1b showed that a large number of target proteins were expressed in the cytoplasm and nucleus , indicating that the DNA vaccine of the present invention successfully expresses Bin1b in e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biotechnology and discloses contraception birth control DNA vaccines. The contraception birth control DNA vaccines comprise plasmids for coding and expressing a nucleotide sequence shown in the formula of SEQ ID NO: 1. A nucleic acid sequence comprising 35th-371th bases of a Bin1b cDNA is used as a target antigen gene and pSG. SS. YL and pSG. SS. C3d. YL are used as appropriate plasmid carriers. Through the target antigen gene and the appropriate plasmid carriers, pSG. SS. YL. Bin1b and pSG. SS. C3d. YL. Bin1b recombinant eukaryotic expression plasmids are constructed and are used as DNA vaccines. The DNA vaccines can realize effective contraception birth control.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a contraceptive and birth control DNA vaccine and a preparation method thereof. Background technique [0002] Family planning is a basic national policy of our country. Effectively controlling the population and significantly improving the quality of the population is a millennium plan related to the prosperity of the country and the prosperity of the country and the nation. The study of safe, effective, controllable, reversible, and simple contraceptive measures not only has important scientific significance, but also has important practical and long-term historical significance for the country and the nation. [0003] With the development of genetic recombination technology and people's in-depth understanding of the molecular basis and detailed mechanism of the fertilization process, the development of effective immune contraception and birth control vaccines may become an ideal me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00A61K39/00A61P15/16
Inventor 孙中义蒋滢周波曾凡春周青松
Owner PEKING UNIV SHENZHEN HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com